'The lower level of anticipated sales to Stryker in 2008 is clearly disappointing but we, as does Stryker, remain confident that the potential for Cormet in the world's largest orthopaedic market is substantial.'

This was 600p at one stage, started falling and then after the above statement. I recall that a broker downgraded target price to 300p.

Cheap at 160p?

thinking of shorting it then?

No position here cynic its a hard one to value as you know.

not worth the effort

I agree.

Down 10% to 45p today not worth the bother.. yet.